Koninklijke Philips N.V.

Koninklijke Philips N.V.

RYLPF

$24.20

Updated: 23/09/2026, 15:14:28

Market Cap
$23.66B
Sector
Healthcare
Industry
Medical - Devices
Country
NL
Stock valuation chart
One-year closing share-price history for RYLPF
Company Profile

Koninklijke Philips N.V. functions as a prominent health technology enterprise, serving markets globally with a significant presence in North America. Its operations are structured around three core segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within its Diagnosis & Treatment division, the company offers a comprehensive array of diagnostic imaging solutions, encompassing advanced magnetic resonance imaging (MRI), computed tomography (CT) systems, X-ray systems, and sophisticated detector-based spectral CT solutions, alongside molecular and hybrid imaging technologies for nuclear medicine. This segment also supplies integrated interventional systems and a range of echography solutions critical for diagnosis, treatment planning, and guidance across cardiology, general imaging, obstetrics/gynecology, and point-of-care scenarios. Furthermore, it provides proprietary software to facilitate diagnostic and interventional practices, coupled with enterprise diagnostic informatics products and services. The Connected Care segment focuses on delivering solutions for acute patient management, emergency care, and sleep and respiratory care needs. It additionally develops electronic medical record (EMR) and comprehensive care management platforms. Moreover, its Personal Health division addresses consumer well-being through offerings such as electric toothbrushes, replacement brush heads, and oral hygiene products, including those for interdental cleaning and teeth whitening. This segment also extends to solutions for infant feeding and digital parenting, as well as male grooming and beauty-focused products. Philips maintains key strategic alliances, notably a collaboration with Ibex Medical Analytics Ltd., working together to globally advance digital pathology and AI-driven solutions for hospitals, healthcare networks, and pathology laboratories. The company also holds a strategic partnership with NICO.LAB. Established in 1891, the firm was formerly known as Koninklijke Philips Electronics N.V. before officially adopting its current name, Koninklijke Philips N.V., in May 2013. Its corporate headquarters are located in Amsterdam, the Netherlands.

USD
OTC
CEO: Roy W. O. Jakobs
Employees: 66,401
https://www.philips.ca
Asset Summaries
Latest generated summaries for RYLPF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for RYLPF.
Share price
$24.20
Market cap
$23.66B
Exchange
OTC
Currency
USD
CEO
Roy W. O. Jakobs
Employees
66,401
IPO date
30/11/2015
Beta
0.916
Last dividend
$0.00
Day range
$24.20 – $25.00
52-week range
$24.20 – $33.00
1-day performance
0.00%
1-year performance
0.00%
Current drawdown (1Y)
-26.65%
CIK
0000313216
CUSIP
N/A
ISIN
NL0000009538
Created
07/12/2025, 14:05:50
Last update
23/09/2026, 15:14:28

Track Koninklijke Philips N.V. with an AI analyst

See which prediction-market events move RYLPF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to RYLPF from your Railway `news_articles` table.

No news found for this symbol.